Chemical Structure : Capmatinib
CAS No.: 1029712-80-8
货号: PC-43511Not For Human Use, Lab Use Only.
Capmatinib (INCB-28060, INC-280) is a highly potent, selective, ATP competitive inhibitor of c-MET kinase with IC50 of 0.13 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥780 | In stock | |
25 mg | ¥1180 | In stock | |
50 mg | ¥1980 | In stock | |
100 mg | ¥2980 | In stock | |
250 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Capmatinib (INCB-28060, INC-280) is a highly potent, selective, ATP competitive inhibitor of c-MET kinase with IC50 of 0.13 nM.
Capmatinib (INCB-28060, INC-280) displays no activity against RONβ, EGFR and HER-3.
Capmatinib (INCB-28060, INC-280) inhibits c-MET phosphorylation (IC50=1 nM) in SNU-5 human gastric cancer cell line, is slightly more potent in H596 and H1437 lung cancer cell lines that express mutant c-MET due to an exon 14 deletion and a R988C mutation.
Capmatinib (INCB-28060, INC-280) inhibits c-MET phosphorylation and tumor growth in c-MET-driven mouse tumor models.
分子量 | 412.42 | |
分子式 | C23H17FN6O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: 12.66 mg/mL |
|
Chemical Name/SMILES |
Benzamide, 2-fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]- |
1. Liu X, et al. Clin Cancer Res. 2011 Nov 15;17(22):7127-38.
2. Brandes F, et al. BMC Cancer. 2015 Feb 19;15:71.
3. Moran-Jones K, et al. Sci Rep. 2015 Jul 3;5:11749.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright